Evidence map›Paper›PMID 40649936›Full record

ArticleInternational journal of molecular sciences2025

Fructose-Induced Glycation End Products Promote Skin-Aging Phenotypes and Senescence Marker Expression in Human Dermal Fibroblasts.

Antonella Rella, Dawn Layman, Rong Dang, Miriam Rafailovich, Robert Maidhof, Nadine Pernodet

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Collagen remodeling in breast cancer progression: from molecular mechanisms to diagnostic and therapeutic opportunities.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Rakkyo (Nutrients · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Antonella RellaResearch and Development, The Estée Lauder Companies, Inc., Melville, NY 11747, USA.
Dawn LaymanResearch and Development, The Estée Lauder Companies, Inc., Melville, NY 11747, USA.ORCID 0009-0000-1881-7930
Rong DangResearch and Development, The Estée Lauder Companies, Inc., Melville, NY 11747, USA.
Miriam RafailovichMaterials Science & Engineering, Stony Brook University, Stony Brook, NY 11794, USA.ORCID 0000-0002-9483-5812
Robert MaidhofResearch and Development, The Estée Lauder Companies, Inc., Melville, NY 11747, USA.ORCID 0000-0002-3268-5855
Nadine PernodetResearch and Development, The Estée Lauder Companies, Inc., Melville, NY 11747, USA.

Funding

Estée Lauder (United States) n/a
6 · The paper itself

Abstract

Skin aging is a multi-factorial process characterized by the progressive deterioration of biomechanical properties and cellular functionality. One such factor is the formation of advanced glycation end products (AGEs), which are known to have detrimental effects on the skin, including stiffening of the extracellular matrix (ECM) and reduction of cellular proliferation. AGEs accumulate because of sugar metabolism dysfunction; however, the direct impact of elevated sugar levels on cellular physiology requires further investigation. Here, we elucidated the effects of elevated fructose levels on skin cell function using in vitro models and hypothesized that high fructose levels adversely impact cell function. By fluorescence microscopy, we observed that high fructose induced different cellularity, cell morphology, and stress fiber appearance than the controls. Skin cells exposed to high fructose levels showed impaired growth and delayed closure in an artificial wound model. Mechanistically, high fructose conditions induce inflammatory cytokines and activate the NFκB pathway. Furthermore, we observed for the first time an increase in the senescence markers

Indexed as

Cellular SenescenceFibroblastsFructoseGlycation End Products, AdvancedSkinSkin AgingBiomarkersCell ProliferationCells, CulturedHumansNF-kappa BPhenotypeBiomarkersFructoseGlycation End Products, AdvancedNF-kappa Badvanced glycation end productsfibroblastsfructosesenescenceskin

Identifiers

PMID40649936
PMCPMC12250180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.